Study of Apatinib as Third-line and Later Therapy in Patients With Small Cell Lung Cancer (SCLC)
Clinical trial NCT02995187 · UNKNOWN
Trial details
- NCT number
- NCT02995187
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2018-05-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.